Found: 31
Select item for more details and to access through your institution.
Muscle Mass Effect: The Importance of Diagnosing and Treating Sarcopenia in Patients with Advanced Chronic Liver Disease.
- Published in:
- Digestive Diseases & Sciences, 2023, v. 68, n. 4, p. 1089, doi. 10.1007/s10620-023-07864-x
- By:
- Publication type:
- Article
Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Current treatment of non-alcoholic fatty liver disease.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Bacterial growth and ceftriaxone activity in individual ascitic fluids in an in vitro model of spontaneous bacterial peritonitis.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1124821
- By:
- Publication type:
- Article
The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The systemic and hepatic alternative renin–angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-28239-2
- By:
- Publication type:
- Article
The impact of hepatic steatosis on portal hypertension.
- Published in:
- PLoS ONE, 2019, v. 14, n. 11, p. 1, doi. 10.1371/journal.pone.0224506
- By:
- Publication type:
- Article
Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 11, p. 1376, doi. 10.1111/apt.17945
- By:
- Publication type:
- Article
Letter: NSBB for fatty liver disease—Still a long way to go. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 8, p. 848, doi. 10.1111/apt.17702
- By:
- Publication type:
- Article
Diabetes impairs the haemodynamic response to non‐selective betablockers in compensated cirrhosis and predisposes to hepatic decompensation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 8, p. 805, doi. 10.1111/apt.17653
- By:
- Publication type:
- Article
Editorial: Negative impact of diabetes mellitus and obesity on the prognosis of patients with chronic liver disease—Authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Disturbances in sodium and chloride homeostasis predict outcome in stable and critically ill patients with cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 71, doi. 10.1111/apt.17507
- By:
- Publication type:
- Article
Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis.
- Published in:
- Wiener Klinische Wochenschrift, 2017, v. 129, n. 1/2, p. 8, doi. 10.1007/s00508-016-1127-1
- By:
- Publication type:
- Article
Anemia and iron deficiency in compensated and decompensated cirrhosis: Prevalence and impact on clinical outcomes.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 9, p. 1619, doi. 10.1111/jgh.14988
- By:
- Publication type:
- Article
Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension.
- Published in:
- Journal of Gastroenterology & Hepatology, 2019, v. 34, n. 12, p. 2164, doi. 10.1111/jgh.14700
- By:
- Publication type:
- Article
Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2017, v. 32, n. 1, p. 184, doi. 10.1111/jgh.13439
- By:
- Publication type:
- Article
Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol‐related cirrhosis.
- Published in:
- Liver International, 2023, v. 43, n. 10, p. 2220, doi. 10.1111/liv.15676
- By:
- Publication type:
- Article
Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2501, doi. 10.1111/liv.15365
- By:
- Publication type:
- Article
Prognostic impact of sarcopenia in cirrhotic patients stratified by different severity of portal hypertension.
- Published in:
- Liver International, 2021, v. 41, n. 4, p. 799, doi. 10.1111/liv.14758
- By:
- Publication type:
- Article
Combination of phosphodiesterase‐5‐inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction.
- Published in:
- Liver International, 2020, v. 40, n. 9, p. 2228, doi. 10.1111/liv.14586
- By:
- Publication type:
- Article
Non‐invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease.
- Published in:
- Liver International, 2020, v. 40, n. 7, p. 1713, doi. 10.1111/liv.14498
- By:
- Publication type:
- Article
Non‐invasive diagnosis of cirrhosis and long‐term disease monitoring by transient elastography in patients with Wilson disease.
- Published in:
- Liver International, 2020, v. 40, n. 4, p. 894, doi. 10.1111/liv.14368
- By:
- Publication type:
- Article
Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension.
- Published in:
- Liver International, 2020, v. 40, n. 2, p. 393, doi. 10.1111/liv.14304
- By:
- Publication type:
- Article
Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease.
- Published in:
- Liver International, 2020, v. 40, n. 1, p. 194, doi. 10.1111/liv.14229
- By:
- Publication type:
- Article
The value of different CT‐based methods for diagnosing low muscle mass and predicting mortality in patients with cirrhosis.
- Published in:
- Liver International, 2019, v. 39, n. 12, p. 2374, doi. 10.1111/liv.14217
- By:
- Publication type:
- Article
Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver disease.
- Published in:
- Liver International, 2019, v. 39, n. 1, p. 127, doi. 10.1111/liv.13943
- By:
- Publication type:
- Article
Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertension.
- Published in:
- Liver International, 2018, v. 38, n. 8, p. 1427, doi. 10.1111/liv.13704
- By:
- Publication type:
- Article
Evaluation of a new balloon occlusion catheter specifically designed for measurement of hepatic venous pressure gradient.
- Published in:
- Liver International, 2015, v. 35, n. 9, p. 2115, doi. 10.1111/liv.12783
- By:
- Publication type:
- Article
Prevalence of anti‐Hepatitis E antibodies and impact on disease severity in non‐alcoholic fatty liver disease.
- Published in:
- Hepatology Research, 2021, v. 51, n. 1, p. 69, doi. 10.1111/hepr.13581
- By:
- Publication type:
- Article
Dysbalanced sex hormone status is an independent predictor of decompensation and mortality in patients with liver cirrhosis.
- Published in:
- Hepatology Research, 2019, v. 49, n. 2, p. 201, doi. 10.1111/hepr.13253
- By:
- Publication type:
- Article